By Eugene Manley, Jr., PhDDirector, Scientific Programs Posted August 26, 2021 This is the first technical leaning update from the Director of Scientific Programs at the Lung Cancer Research Foundation. […]
As fall 2021 approaches, we’ve seen a number of interesting developments in lung cancer research in the year so far. Several new findings were introduced at the American Association for […]
Dr. Trudy Oliver, a 2018 LCRF research grant recipient, explains how research affects what lung cancer patients experience when they go for treatment.
LCRF 2013 grant recipient Thales Papagiannakopoulos, PhD, and a team of cancer biologists from the Massachusetts Institute of Technology (MIT) have discovered mutations and other genetic disturbances that arise at certain stages of lung cancer.
The research from a study funded by LCRF in 2010 and 2011 was just published in the Journal of the National Cancer Institute. The study found that cells appearing normal may actually be harbingers of lung cancer. Join us in congratulating Humam Kadara, PHD on his work!
